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INTRODUCTION
Preeclampsia is a maternal disease marked by hyper-
tension and proteinuria after 20 weeks of gestational
age. In Indonesia, the incidence of preeclampsia is in
the range of 3 - 10%, and contributes up to 39.5% in
the maternal cause of death in 2001, and rose signifi-
cantly to 55.56% in 2002.1 In Dr. Moewardi hospital
Surakarta, preeclampsia related maternal death toll
was 25, from the total of 37 maternal deaths in 1956
labor, in 2008.2
Although various treatment had been sucessfully
developed, preeclampsia related maternal morbidity
and mortality are yet to show any significant improve-
ment. This condition was partly caused by the lack
of understanding of its ethiology and pathogenesis/
mechanism. At present, many theories have tried to
explain the pathogenesis of preeclampsia, from ge-
netic predisposition, trombophilia, endocrinopathy,
vasculopathy, placental ischaemia, oxidatif stress, to
immune maladaptation.3
In normal pregnancy, the fetus is a semialograf sys-
tem (which brought with it, the father’s antigen), ac-
cepted by mother. This is a phenomenon brought for-
ward by the maternal tolerance in its immune respons
mechanism, both local (between the trophoblast tissue
and the immune cells from maternal decidua in early
period of pregnancy) and systemic (between the sinti-
tiotrophoblast and maternal immune cells in circulati-
on/systemic).4,5 The cause for this immune tolerance
is not yet understood, yet there is a possibility that
the placenta possesses a unique type of human leuco-
cyte Antigen and specific inflammatory cell (large
granular lymphocyte/LGL), thus, the trophoblast nei-
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Abstrak
Tujuan: Penelitian ini bertujuan untuk menganalisis ekspresi
protein HLA-G, Hsp-70 dan VCAM-1 pada trofoblas perempuan
preeklampsia dan perempuan hamil normal. Menganalisis adakah
hubungan kausatif adanya penurunan HLA-G terhadap peningkat-
an ekspresi Hsp-70 dan VCAM-1 pada preeklampsia.
Metode: Jenis penelitian observasional analitik dengan rancang
bangun potong lintang.
Hasil: Pada trofoblas ibu hamil preeklampsia ekspresi HLA-G
lebih rendah (p = 0,01) dibandingkan ekspresinya pada perempuan
hamil normal. Ekspresi Hsp-70 (p = 0,02) dan VCAM-1 (p = 0,00)
pada preeklampsia lebih tinggi dibandingkan dengan perempuan
hamil normal. Dengan analisis regresi terbukti bahwa HLA-G
yang rendah merupakan prediktor untuk terjadinya peningkatan
Hsp-70 dan VCAM-1 pada trofoblas.
Kesimpulan: HLA-G yang rendah pada trofoblas merupakan
prediktor untuk terjadinya kerusakan endotel pada perempuan pre-
eklampsia.
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ther expresses the class Ia/classic major histocomati-
bility complex (MHC), namely the HLA-A and HLA-
B, or the class II MHC molecule. On the other hand,
the trophoblast does express class Ib/ non classic
HLA-A such as HLA-G, HLA-E, HLA-F and HLA-C
(class Ia). Moreover, there is an abundance of uterine
Natural Killer (NK) cells in the decidua, which ex-
presses a range of diverse receptors known to recog-
nize the class Ib HLA molecule being expressed by
the throphoblast, and thus helps the trophoblast to
elude from an NK cell induced lysis.6,7
Should there be an absent, or lack there of, HLA-G
expression, the ability of the trophoblast ability to in-
vade uterus will be reduced, or hindered (as the tro-
phoblast is assumed to be a non self entity). And in
the same instant, the maternal NK cell will destroy
the efore mentioned trophoblast. Without the proper
trophoblast invasion, maternal artery would not be re-
modeled, and caused a reduced uteroplacental flow,
which resulted in placental hypoxia/ischemia and pre-
eclampsia. This circumstance supports the hypothesis
that preeclampsia is caused by an abnormality in ma-
ternal and fetal local immune recognition at the utero-
placental level.8
Heat Shock Protein (Hsp) is known to protect cells
from various cytotoxic disturbances. Induction of in-
creased stress protein is related to organ exposure to
stress. Induced stress proteins can protect cells from
stress-triggered damage by preventing protein denatu-
ration and, or, by repairing the damage (as a chapero-
ne protein).
During physiologic stress, Hsp over expression
plays an important role in cell protection from apop-
tosis. As metabolically active system are needed to
preserve the pregnancy, there is a possibility that the
placenta tissue, especially in preeclampsia, is suffer-
ing from a redundant stress; this could be the reason
for the increase in Hsp production.
Data reported by Xu et al (1997) showed that Hsp
play a role, both in the repair of proteins denaturated
by oxidative stress, and in the folding of new polypep-
tide chain. This underlined the Hsp-70 importance in
preserving homeostasis during oxidative stress, and
oxydan then free radical.9 These can trigger a defense
mechanism from oxidative stress by increasing Hsp-
70 expression, and in preeclampsia, protect the cell
from apoptosis. It was suggested that Hsp-70 increase
is related with placenta in preeclamptic women. The
increased Hsp expression showed a multiple protec-
tion effect on cell response to stress.10
Dysfunctional endothelial cells underwent activa-
tion by producing surface cell proteins that facilitate
adhesion with numerous inflammatory cells. This in-
duction process is facilitated by pro inflammatory cy-
totoxin, like TNF-α and IL-1 β produced by various
inflammatory cells and activated endothelial cells. A
handful substance called the leucocyte-endhotial ad-
hesion molecule has been identified, including E-se-
lectin, VCAM-1 and ICAM-1.11
This study was intended to analyze HLA-G, Hsp-
70 and VCAM-1 proteins expression in the tropho-
blast of preeclamptic, and normal pregnancy, and to
assess any causative relationship between HLA-G,
Hsp-70 and VCAM-1 expressions.
METHOD
This study was conducted in the Obgyn Department
of Medical Faculty of Sebelas Maret University/Dr.
Moewardi hospital Surakarta, from October 2008 to
March 2009. Immunohistochemical staining and ob-
servation was conducted in Pathology Anatomy De-
partment Medical Faculty of Airlangga University Su-
rabaya.
This is an observational analytic study with cross
sectional design. The study was conducted on fullterm
pregnant women with severe preeclampsia, and on
normal pregnant women, to analyze trophoblastic
HLA-G, Hsp-70 and VCAM-1 proteins expression.
The number of sample needed to test the hypothe-
sis was determined using replication from Steel and
Torrie.12 Based on that formula, the number of sample
needed for each group was 10.
Inclusion criteria
Primigravida age ≤ 35 years of age with good nutri-
tional status, full-term pregnant with single fetus,
without chronic hypertension, did not suffer from
early rupture of the membrane, without heart disease,
kidney disorder, diabetes mellitus or liver disorder,
infection or prolonged labor.
Exclusion criteria
Patients who did not wish to participate in the study,
or those who initially participate and drop out, or
died, in the duration of the study.
To obtain homogenous samples, we perform tests
on subjects who underwent labor in dr. Moewardi
hospital Surakarta fulfilling our inclusion criteria to
determine existence of any exclusion criteria. Those
who passed, were offered to enroll in our study.
Two groups of samples were obtained. The first is
the case group, labor with severe preeclampsia, while
the second group consisted of labor with normal preg-
nancy, which served as our control group. Immuno-
histochemical studies were performed on trophoblasts
of each sample to assess their HLA-G, Hsp-70 and
VCAM-1 proteins expression. The result was analy-
zed using t test to analyze any causative relation,
while linier regression analysis was used to determine
their usability as predictor.
RESULT
The characteristic of Research Subject
Table 1. Data distribution of research subject.
Variable n Min Max Average SD
Maternal age (year) 20   17.00   34.00  25.85    4.77
Gestational age (week) 20   37.00   41.00  38.55    1.19
Systole Blood Pressure (mmHg) 20   90.00  180.00 140.00   31.11
Diastole Blood Pressure (mmHg) 20   60.00  120.00  93.50   19.26
Hemoglobin (gr/dl) 20   10.40   14.20  12.39    1.25
Blood Glucose level (mg/dl) 20   58.00  113.00  84.91   15.49
Ureum (mg/dl) 20   12.00   34.00  19.35    6.01
Creatinine (mg/dl) 20    0.60    1.30   0.78    0.18
SGOT (U/I) 20   10.00   42.00  23.40    7.71
SGPT (U/I) 20    7.00   55.00  21.45   10.29
Leucocytes count (103/μ1) 20 4200.00 8000.00   6.14 1197.98
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Table 2. Test for Mean Difference on Research Subject, Based on type of group (Preeclampsia and Normal pregnancy Group).
Variable Group n Mean SD p  score
Maternal age (years) Preeclampsia
Normal
10
10
27.50
24.20
5.58
3.29
0.12
Gestational age (weeks) Preeclampsia
Normal
10
10
38.30
38.80
1.41
0.91
0.36
Systole Blood Pressure (mmHg) Preeclampsia
Normal
10
10
169.00
111.00
8.75
9.94
0.00*
Diastole Blood Pressure (mmHg) Preeclampsia
Normal
10
10
111.00
76.00
5.67
8.43
0.00*
Hemoglobin (g/dl) Preeclampsia
Normal
10
10
12.22
12.57
1.42
1.10
0.54
Glucose Blood level (mg/dl) Preeclampsia
Normal
10
10
83.30
86.53
17.51
13.95
0.65
Ureum (mg/dl) Preeclampsia
Normal
10
10
20.59
18.12
7.74
3.59
0.37
Creatinine Preeclampsia
Normal
10
10
0.83
0.74
0.24
0.06
0.28
SGOT (U/I) Preeclampsia
Normal
10
10
24.20
22.60
8.91
6.68
0.65
SGPT (U/I) Preeclampsia
Normal
10
10
22.90
20.00
12.45
8.00
0.54
Leucocytes count (103/μ1) Preeclampsia
Normal
10
10
5800.00
6480.00
1187.90
1166.95
0.21
Parity Preeclampsia
Normal
10
10
1.00
1.00
0.00
0.00
-
*Significant value p < 0.05
Figure 4. Hsp-70 in normal pregnancy.
Figure 1. HLA-G in preeclampsia. Figure 2. HLA-G in normal pregnancy.
Figure 3. Hsp-70 in preeclampsia.
Trophoblastic HLA-G, Hsp-70 and VCAM-1 Expressions in Preeclampsia and Normal Pregnancy
HLA-G expressions in Preeclampsia were lower, compared to normal pregnancy (p = 0.01).
Hsp-70 expressions in preeclampsia were higher, compared to normal pregnancy (p = 0.02).
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Linier Regression Analysis
? Linear regression analysis for HLA-G and Hsp-70
expression resulted in p = 0.01. Thus the HLA-G
expression is a predictor for the increased Hsp-70
expression in Preeclampsia etiopathogenesis.
In Figure 7 we can see that the decrease in HLA-G
expression resulted in a linear increase in Hsp-70
expression.
? Linear regression analysis for Hsp-70 and VCAM-
1 expression resulted in a p value of 0.04. Thus
the Hsp-70 expression is a predictor for the in-
creased VCAM-1 expression in Preeclampsia etio-
pathogenesis.
In Figure 8 we can see that the increase in Hsp-70
expression resulted in a linear increase in VCAM-1
expression.
DISCUSSION
Low trophoblastic HLA-G Protein Expression is
a factor for preeclampsia etiopathogenesis
Trophoblast is the only conception cell in direct con-
tact with maternal tissue or blood. It is genetically
identical with the fetus tissue. In normal pregnancy,
this tissue expresses a large amount of HLA-G, a non
classic class Ib MHC molecule, during its invasion
into the uterus. Since HLA-G is numeric, it is con-
sidered as self, and therefore, if sufficiently expressed,
does not trigger maternal immunologic response. The
lack, or absent, of HLA-G expression prevents tro-
phoblastic invasion into maternal tissue, and proper
vascular invasion. This failure creates a placental de-
fect resulted in a decreased uteroplacental blood flow
that can be seen on preeclampsia.13
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Figure 7. Graphic of the relation between HLA-G and Hsp-70
in Preeclampsia etiopathogenesis.
X = predictor = HLA-G
Y = dependent variable = Hsp-70
Figure 6. VCAM-1 in normal pregnancy.
Trophoblastic VCAM- 1 expressions in preeclampsia were highercompared to normal pregnancy (p = 0.00).
Figure 5. VCAM-1 in preeclampsia.
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Figure 8. Graphic of the relation between Hsp-70 and VCAM-1
expression in Preeclampsia etiopathogenesis.
X = predictor = Hsp-70
Y = dependent variable = VCAM-1
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Result of our study showed that trophoblast taken
from preeclamptic patients had lower HLA-G expres-
sion mean of distribution (82.00 ± 26.45%/field of
view) compared to normal pregnancy (122.00 ± 20.74
%/field of view). Statistic analysis also confirmed a
significant difference with p = 0.01 (< 0.05). This
result confirmed Goldman’s observation (2000) that
9 from 10 pregnant mothers with preeclampsia show-
ed low HLA-G expression. Therefore, trophoblast lac-
king HLA-G expression is vulnerable to maternal im-
mune system attack. This defective trophoblast could
not effectively invades maternal’s spiral artery, and
thus the later developed vascular system could not
provide sufficient nutrition needed by the developing
placenta. This inadequately perfused placenta may in-
itiate a series of systemic events known as preeclamp-
sia.8
Yie (2004) conducted a study on serum and pla-
cental HLA-G concentration. The result showed that
both serum and placental HLA-G on women with pre-
eclampsia was significantly lower (median = 0.026
ng/ml in serum and median = 0.026 ng/ml in placenta)
compared to the concentration found on women with
normal pregnancy (median = 0.093 ng/ml in serum
and median 0.088 ng/ml in placenta). The conclusion
of this study was that the decrease of HLA-G expres-
sion in human placenta and (subsequently) the de-
crease of HLA-G released in maternal circulation may
impair the feto-maternal immune relationship. This
may resulted in preeclampsia. It was concluded that
the immune mechanism might play a central role in
first stage of preeclampsia pathogenesis. The limited
and naturally monomorphic HLA-G expression had
led many to hypothesized that HLA-G could be for-
mulated as a universally accepted identity card, al-
lowing the trophoblast to avoid rejection. 
The lack of, or significantly low, HLA-G expres-
sion on early stages of pregnancy may result in total
fetal loss. Pregnancy with a mild degree of low HLA-
G expression can continue into the first trimester with
placental ischemia effect, which may later develop in-
to preeclampsia.14
Low, or altered, HLA-G expression may result in
functional disorder. Low placental HLA-G concentra-
tion in the first trimester of pregnancy in mixed lym-
phocytes reaction can multiply the amount of both
type Th-1 cytokine and allocytotoxic T lymphocyte
(CTL) released. While on the other hand, a high/suf-
ficient concentration of HLA-G can increase the type
Th-2 cytokine, and decrease the type Th-1 cytokine
and CTL response. The effect of low HLA-G can in-
fluence placentation, resulted in weak intertitial tro-
phoblast invasion and scant endovascular invasion
(meanwhile the endovascular trophoblast cell itself
expressed HLA-G protein to protect cells from NK
cell related lyses) and also systemically influenced en-
dothelial cells in pregnant women who would later
emerge as preeclampsia.15
The TNF-α, IL-2 and IFN-γ producing type Th-1
T cell becomes the tempest of pregnancy, while the
type Th-2 T cell that secreted IL-3, IL-4, IL-10, IL-13
and TNF-β2 plays a protecting role. Study by Yie
(2004) involving a reaction test by mixing lympho-
cyte in vitro, found that high concentration of HLA-G
produced a type Th-2 response, while the opposite
produced a type Th-1 response. Low HLA-G might
disturb its abi-lity to protect feto-placental unit from
generation of T cell cytotoxic and, or, lyses by NK
cell.14
Unlike Yie (2004), immunohistochemical study by
Datema et al (2003) stated that there was no differ-
ence between HLA-G expression in preeclamptic and
normal placenta. This opposite observation may come
from the small number of sample used in Datea study,
which consisted of 4 placentas each, for the pree-
clamptic, and normal group.16
High trophoblastic HSP-70 protein expression is
the etiopathogenesis of preeclampsia
Hsp-70 is known to be able to protect cell from cy-
totoxic disturbance and is expressed as a response to
stress, acted as a chaperone for cellular protein, and
then binds the emerging polypeptide to prevent pre-
mature folding, and to translocate the protein into the
organels.
Over expression of Hsp-70 has an important mean-
ing on cell protection during physiologic stress in
apoptosis process. Just as metabolically active tissue
is important in maintaining pregnancy, so is the pla-
centa system in preeclampsia suffering from tremen-
dous stress. This is also the reason that triggers the
Hsp-70 production. The result is the increased Hsp-70
and alterations in placental endothelial cells. The in-
creased of placental Hsp-70 expression in preeclamp-
sia might demonstrate a multiple protection effect on
cellular response toward stress.
In this study, we found that the trophoblastic Hsp-
70 expression of pregnant women with preeclampsia
(31.90% ± 6.24%/field of view) is higher, compared
to normal pregnancy(1920 ± 8.80%/scope of view), a
difference with statistic significance, with p = 0.02 (p
< 0.05). This result was similar to those obtained ear-
lier, such as Padmini (2008) which studied the Hsp-70
expression either in constitutive (HSC-70) or induc-
ible (Hsp-70) form, in relation to oxidative stress con-
dition on placenta tissue, in preeclamptic, and normo-
tensive pregnancy as a control group. The result was
that the placental concentration of HSC-70 and Hsp-
70 was significantly higher in preeclampsia (p <
0.001) compared to the control group. It was deducted
that high level of Hsp-70 is related with placenta of
preeclamptic women. The increased expression show-
ed a multiple protection effect of celllular response
to stress.10 Hung and colleagues (2001) concluded in
their study that the increase of Hsp-70 in placental
tissue was a compensatory response to ischemia as an
example of oxidative stress in preeclampsia.17
That condition (the increase of Hsp-70) in tro-
phoblast might indicate the multiple protection effect
of cellular response to the stress.
Higher expression of VCAM-1 protein in the tro-
phoblast tissue is an etiopathogenesis factor of
preeclampsia
The increase of serum and placental VCAM-1 con-
centration in women during the second trimester of
pregnancy, who later developed preeclampsia, was in-
dicative of an endothelial alteration in women with
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preeclamptic tendency, weeks before the onset of
clinical symptoms. This finding gave a rationale that
there was an increased endothelial damage, and hope-
fully could serve as a predictive parameter in identi-
fying pregnant women with the risk for preeclamp-
sia.18
Our study found higher trophoblastic VCAM-1
protein expression in preeclamptic pregnancy com-
pared to the control group.
Austgulen et al reported an increased VCAM-1 ex-
pression in pregnant women with preeclampsia. Zhon
and colleagues stated that preeclampsia is related to
a failure of human trophoblast to imitate vascular phe-
notype adhesion. The alteration of VCAM-1 during
the first trimester of pregnancy might be mechanically
related with the increase of its expression in the se-
cond trimester, and ended in the development of pre-
eclampsia during the third trimester of pregnancy.18
John T and colleagues (2003) compared VCAM-1
expression in placental bed (endothelium of the spiral
artery, as well as the trophoblast cells) from 20 preg-
nant women with preeclampsia and 20 women with
normal pregnancy using Immunohistochemical techni-
que. VCAM-1 expression in pregnant women with
preeclampsia was higher than normal pregnancy; al-
though the difference was not statistically signifi-
cant.19
CONCLUSION
In preeclampsia, the HLA-G protein expression of is
lower than that of normal pregnancy. Hsp-70 and
VCAM-1 protein expression in preeclampsia are high-
er compared to that of normal pregnancy, and there
is a causative relationship between the low expression
of HLA-G, to the increase of Hsp-70 and VCAM-1
protein expression in women with preeclampsia.
SUGGESTION
In order to obtain a more optimum result related to
the etiopathogenesis of preeclampsia, the writer sug-
gested a series of examination to exclude factors that
can result in an altered HLA-G protein expression (in-
creased, lowered, or a lack there of) in early preg-
nancy period, such as examination for HLA-G gene
polymorphism, virus infections (i.e. Human Citome-
galovarious (HCMV), herpes virus simplex 1), and
examination for specific immunity on multiparous
women who changed her partner, or was pregnant by
a different partner.
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